Clinical Trials

30 enrolled

Immunoglobulin Light-chain Amyloidosis

NCT03499808 2025-09-09

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

GastrointestinalOtherPlasma cell

43 enrolled 23 charts

Lymphadenopathy, Immunoglobulin Light-chain Amyloidosis, Constipation, Diarrhea, Gastrointestinal Hemorrhage, Hepatomegaly, Macroglossia, Nausea, Purpura

NCT04617925 2025-09-05

EMN27

35 enrolled

Phase 2 Not yet recruiting

Immunoglobulin Light-chain Amyloidosis

NCT07085728 2025-08-22

Testing the Investigational Agent Combination of Daratumumab, Bortezomib, and Dexamethasone Compared to the Usual Treatment of Cyclophosphamide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients With Kidney Failure

74 enrolled

Phase 2 Not yet recruiting

Multiple Myeloma

NCT07107529 2025-08-12

Study for Frail Patients With Newly Diagnosed Multiple Myeloma Treated With Daratumumab With Teclistamab or Talquetamab.

150 enrolled

Phase 2 Active not recruiting

Multiple Myeloma

NCT03896737 2025-08-11

Daratumumab-bortezomib-dexamethasone (Dara-VCd) vs Bortezomib-Thalidomide-Dexamethasone (VTd), Then Maintenance With Ixazomib (IXA) or IXA-Dara

401 enrolled

Disease, Multiple Myeloma

NCT06171685 2025-07-15

MMRC Horizon One Adaptive Platform Trial Evaluating Therapies in RRMM

300 enrolled

Phase 2 Active not recruiting

Multiple Myeloma

NCT05123131 2025-07-08

Isa-RVD

54 enrolled

Phase 2 Active not recruiting

Multiple Myeloma

NCT04166565 2025-04-17

EMN19

41 enrolled

Multiple Myeloma

NCT03683277 2025-02-19

IFM2014-01

Phase 2 Terminated

26 enrolled

Multiple Myeloma, Recurrence, Genetic Diseases, Inborn

NCT01903811 2024-12-20

S1304, Carfilzomib and Dexamethasone for Treating Patients With Relapsed or Refractory Myeloma

143 enrolled 14 charts

Multiple Myeloma, Recurrence

NCT06183489 2024-10-18

ERASMM

50 enrolled

Smoldering Multiple Myeloma

NCT06189833 2024-04-23

TAURUS

200 enrolled

Multiple Myeloma

NCT01190787 2024-01-23

Subcutaneous Velcade Plus Oral Melphalan and Prednisone or Plus Cycloposphamide and Prednisone or Plus Prednisone

150 enrolled

Disease, Multiple Myeloma

NCT01913730 2023-12-13

Maintenance Therapy With Subcutaneous Bortezomib

63 enrolled

Multiple Myeloma, Recurrence

NCT01524926 2023-12-11

CREATE

LymphoidPlasma cellSarcoma

582 enrolled

Granuloma, Plasma Cell, Lymphoma, Large-Cell, Anaplastic, Sarcoma, Clear Cell, Rhabdomyosarcoma, Alveolar, Sarcoma, Alveolar Soft Part

NCT05082675 2023-09-11

Stem Cell Translpantation in Multiple Myeloma

357 enrolled

Multiple Myeloma, Neoplasms, Plasma Cell

NCT01346787 2023-09-08

CCD

58 enrolled

Multiple Myeloma

NCT02597062 2023-08-28

High-Dose Weekly Carfilzomib Plus Cyclophosphamide and Dexamethasone in the Treatment of Relapsed Multiple Myeloma

76 enrolled 9 charts

Multiple Myeloma

NCT00305812 2023-08-04

Lenalidomide and Melphalan in Treating Patients With Previously Untreated Multiple Myeloma

51 enrolled

Multiple Myeloma, Neoplasms, Plasma Cell

NCT01145989 2023-08-04

A Study of AT9283 in Patients With Relapsed or Refractory Multiple Myeloma

8 enrolled

Multiple Myeloma, Recurrence

NCT00003353 2023-06-22

High-Dose Melphalan Plus Peripheral Stem Cell Transplantation in Treating Patients With Primary Systemic Amyloidosis

Immunoglobulin Light-chain Amyloidosis, Multiple Myeloma, Neoplasms, Plasma Cell

NCT00014508 2023-06-22

Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00003153 2023-06-15

Biological Therapy in Treating Patients With Multiple Myeloma That Has Recurred Following Bone Marrow Transplantation

22 enrolled

Multiple Myeloma, Neoplasms, Plasma Cell

NCT01045681 2020-12-07

BVD

75 enrolled

Multiple Myeloma

NCT02219178 2020-07-17

Study of the Efficacy and Safety of RsqVD Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma

42 enrolled

Multiple Myeloma

NCT00006890 2020-04-02

Thalidomide and Prednisone Following Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

67 enrolled

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00064337 2018-08-09

S0115, High-Dose Melphalan and Autologous Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Primary Systemic Amyloidosis

104 enrolled 6 charts

Immunoglobulin Light-chain Amyloidosis, Multiple Myeloma

NCT00124579 2018-08-09

S0417 Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase 2 Terminated

7 enrolled 6 charts

Multiple Myeloma

NCT00109889 2017-04-24

S0340 MRI and Fludeoxyglucose F18 PET in Diagnosing Solitary Plasmacytoma

Phase 2 Terminated

2 enrolled

Multiple Myeloma, Plasmacytoma

NCT00040937 2016-12-08

S0204 Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma

147 enrolled 6 charts

Multiple Myeloma

NCT00002849 2015-03-06

S9628 Dexamethasone Plus Interferon Alfa in Treating Patients With Primary Systemic Amyloidosis

93 enrolled

Immunoglobulin Light-chain Amyloidosis, Multiple Myeloma

NCT01055301 2015-03-06

S0833, Bortezomib, Thalidomide, Lenalidomide, Combination Chemotherapy, and Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma

Phase 2 Withdrawn

Multiple Myeloma

NCT00814541 2014-12-31

PAD. ICORG 05-01, V11

53 enrolled

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00847639 2014-04-04

07-REV

30 enrolled

Multiple Myeloma

NCT00002657 2013-01-24

SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant

LymphoidOther hematologic neoplasmPlasma cell

20 enrolled

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Neoplasms, Plasma Cell

NCT00110045 2012-09-24

Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant

BreastCNSDermatologicGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmPlasma cell

171 enrolled

Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Immunoglobulin Light-chain Amyloidosis, Carcinoma, Ovarian Epithelial, Ataxia Telangiectasia, Blast Crisis, Breast Neoplasms, Burkitt Lymphoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Infections, Leukemia, Hairy Cell, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Mycosis Fungoides, Myeloproliferative Disorders, Neoplasms, Neuroblastoma, Polycythemia Vera, Sezary Syndrome, Testicular Neoplasms, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Prolymphocytic, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Leukemia, Large Granular Lymphocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis, Intraocular Lymphoma

NCT00772811 2011-02-17

Flu-Mel